BR0311777A - Composição de vesìcula meningocócica multivalente, vacina para o tratamento de doença neisserial, métodos para fabricação de composição de vesìcula meningocócica multivalente e para prevenção ou tratamento de doença neisserial, e, uso de uma quantidade imunologicamente eficaz da vacina - Google Patents
Composição de vesìcula meningocócica multivalente, vacina para o tratamento de doença neisserial, métodos para fabricação de composição de vesìcula meningocócica multivalente e para prevenção ou tratamento de doença neisserial, e, uso de uma quantidade imunologicamente eficaz da vacinaInfo
- Publication number
- BR0311777A BR0311777A BR0311777-4A BR0311777A BR0311777A BR 0311777 A BR0311777 A BR 0311777A BR 0311777 A BR0311777 A BR 0311777A BR 0311777 A BR0311777 A BR 0311777A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- vaccine
- vesicle composition
- neisserial disease
- multivalent meningococcal
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 5
- 241001212279 Neisseriales Species 0.000 title abstract 4
- 230000002265 prevention Effects 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0213622.4A GB0213622D0 (en) | 2002-06-13 | 2002-06-13 | Vaccine Corporation |
| PCT/EP2003/006094 WO2003105890A2 (en) | 2002-06-13 | 2003-06-10 | Vaccine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0311777A true BR0311777A (pt) | 2005-03-29 |
Family
ID=9938532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0311777-4A BR0311777A (pt) | 2002-06-13 | 2003-06-10 | Composição de vesìcula meningocócica multivalente, vacina para o tratamento de doença neisserial, métodos para fabricação de composição de vesìcula meningocócica multivalente e para prevenção ou tratamento de doença neisserial, e, uso de uma quantidade imunologicamente eficaz da vacina |
Country Status (20)
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03000822A (es) | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
| GB2414667A (en) * | 2004-06-03 | 2005-12-07 | Isis Innovation | Vaccine compositions of N. meningitidis PorA and FetA antigens |
| GB0419627D0 (en) * | 2004-09-03 | 2004-10-06 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
| CN101107007B (zh) | 2005-01-27 | 2011-08-17 | 奥克兰儿童医院及研究中心 | 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗 |
| JP5792920B2 (ja) * | 2005-12-22 | 2015-10-14 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
| SI2097102T1 (sl) | 2006-09-07 | 2012-09-28 | Glaxosmithkline Biolog Sa | Kombinirano cepivo, ki ima zmanjšane količine antigena za poliovirus |
| HRP20120433T1 (en) | 2007-10-19 | 2012-07-31 | Novartis@Ag | Meningococcal vaccine formulations |
| US20090124573A1 (en) | 2007-11-09 | 2009-05-14 | Sarkis Mazmanian | Immunomodulating compounds and related compositions and methods |
| CN101952728B (zh) * | 2008-02-01 | 2016-05-11 | 圣诺菲·帕斯图尔有限公司 | 用于诊断肺炎链球菌的试验 |
| SI2268618T1 (sl) | 2008-03-03 | 2015-09-30 | Novartis Ag | Spojine in sestavki kot modulatorji aktivnosti TLR |
| AU2009329193A1 (en) | 2008-12-17 | 2011-07-14 | Novartis Ag | Meningococcal vaccines including hemoglobin receptor |
| CA2765112A1 (en) | 2009-06-10 | 2010-12-16 | Novartis Ag | Benzonaphthyridine-containing vaccines |
| AU2010288239B2 (en) | 2009-08-27 | 2014-01-16 | Novartis Ag | Adjuvant comprising aluminium, oligonucleotide and polycation |
| JO3257B1 (ar) | 2009-09-02 | 2018-09-16 | Novartis Ag | مركبات وتركيبات كمعدلات لفاعلية tlr |
| US9950062B2 (en) | 2009-09-02 | 2018-04-24 | Glaxosmithkline Biologicals Sa | Compounds and compositions as TLR activity modulators |
| EP2486940B1 (en) * | 2009-10-08 | 2017-10-04 | Aeon Medix Inc. | Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof |
| WO2011057148A1 (en) | 2009-11-05 | 2011-05-12 | Irm Llc | Compounds and compositions as tlr-7 activity modulators |
| JP5814933B2 (ja) | 2009-12-15 | 2015-11-17 | ノバルティス アーゲー | 免疫増強化合物の均質な懸濁物およびその使用 |
| KR20120107121A (ko) * | 2009-12-22 | 2012-09-28 | 사노피 파스퇴르 리미티드 | 면역원성 조성물 |
| WO2012020326A1 (en) | 2010-03-18 | 2012-02-16 | Novartis Ag | Adjuvanted vaccines for serogroup b meningococcus |
| EA031379B1 (ru) | 2010-03-23 | 2018-12-28 | Новартис Аг | Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний |
| HUE040658T2 (hu) * | 2010-04-07 | 2019-03-28 | California Inst Of Techn | Vivõanyag vegyület mukózus membránhoz juttatásához és kapcsolódó készítmények, eljárások és rendszerek |
| CA2810971C (en) | 2010-09-10 | 2020-11-03 | Novartis Ag | Developments in meningococcal outer membrane vesicles |
| US20150147356A1 (en) | 2011-05-12 | 2015-05-28 | Alan Kimura | Antipyretics to enhance tolerability of vesicle-based vaccines |
| US9539281B2 (en) | 2011-07-12 | 2017-01-10 | The Brigham And Women's Hospital, Inc. | Lipid-containing PSA compositions, methods of isolation and methods of use thereof |
| MX2014008988A (es) | 2012-02-02 | 2014-08-27 | Novartis Ag | Promotores para aumento de expresion de proteinas en meningococo. |
| WO2013132040A2 (en) | 2012-03-08 | 2013-09-12 | Novartis Ag | In vitro potency assay for protein-based meningococcal vaccines |
| ES2847923T3 (es) | 2012-06-14 | 2021-08-04 | Glaxosmithkline Biologicals Sa | Vacunas contra el meningococo del serogrupo X |
| BR112015005056A2 (pt) | 2012-09-06 | 2017-11-21 | Novartis Ag | vacinas de combinação com sorogrupo b meningococcus e d/t/p |
| WO2016201342A1 (en) | 2015-06-10 | 2016-12-15 | California Institute Of Technology | Sepsis treatment and related compositions methods and systems |
| CN108135167B (zh) | 2015-08-19 | 2021-07-09 | 哈佛学院院长及董事 | 脂化psa组合物和方法 |
| WO2018014012A1 (en) | 2016-07-15 | 2018-01-18 | President And Fellows Of Harvard College | Glycolipid compositions and methods of use |
| JP7104027B2 (ja) | 2016-09-02 | 2022-07-20 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 淋菌に対するワクチン |
| CN116670157A (zh) * | 2020-10-23 | 2023-08-29 | Omvax公司 | 用于抗淋病奈瑟球菌的疫苗接种的组合物和方法 |
| GB202115077D0 (en) | 2021-10-21 | 2021-12-08 | Glaxosmithkline Biologicals Sa | Assay |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001510169A (ja) * | 1997-07-17 | 2001-07-31 | ノース アメリカン ワクチン, インコーポレイテッド | B型髄膜炎菌性ポーリンおよびH.influenzae多糖体を含む免疫原性結合体 |
| GB9918319D0 (en) * | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
| MXPA03000822A (es) * | 2000-07-27 | 2004-11-01 | Childrens Hosp & Res Ct Oak | Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis. |
-
2002
- 2002-06-13 GB GBGB0213622.4A patent/GB0213622D0/en not_active Ceased
-
2003
- 2003-06-10 JP JP2004512791A patent/JP2005531614A/ja active Pending
- 2003-06-10 CL CL200301192A patent/CL2003001192A1/es unknown
- 2003-06-10 AU AU2003236734A patent/AU2003236734A1/en not_active Abandoned
- 2003-06-10 MX MXPA04012568A patent/MXPA04012568A/es not_active Application Discontinuation
- 2003-06-10 NZ NZ560766A patent/NZ560766A/en not_active IP Right Cessation
- 2003-06-10 CN CNB038162822A patent/CN100387298C/zh not_active Expired - Fee Related
- 2003-06-10 RU RU2005100509/13A patent/RU2005100509A/ru not_active Application Discontinuation
- 2003-06-10 EP EP03735599A patent/EP1565211A2/en not_active Ceased
- 2003-06-10 KR KR1020047019991A patent/KR20050049431A/ko not_active Ceased
- 2003-06-10 BR BR0311777-4A patent/BR0311777A/pt not_active IP Right Cessation
- 2003-06-10 CA CA002488782A patent/CA2488782A1/en not_active Abandoned
- 2003-06-10 WO PCT/EP2003/006094 patent/WO2003105890A2/en not_active Ceased
- 2003-06-10 US US10/529,064 patent/US20060110412A1/en not_active Abandoned
- 2003-06-11 UY UY27843A patent/UY27843A1/es unknown
- 2003-06-11 PE PE2003000583A patent/PE20040562A1/es not_active Application Discontinuation
- 2003-06-11 AR ARP030102096A patent/AR040204A1/es not_active Application Discontinuation
-
2004
- 2004-11-25 ZA ZA200409547A patent/ZA200409547B/en unknown
- 2004-12-10 CU CU20040285A patent/CU23552A1/es active IP Right Grant
-
2005
- 2005-01-11 NO NO20050132A patent/NO20050132L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| UY27843A1 (es) | 2003-12-31 |
| CA2488782A1 (en) | 2003-12-24 |
| MXPA04012568A (es) | 2005-09-21 |
| WO2003105890A2 (en) | 2003-12-24 |
| KR20050049431A (ko) | 2005-05-25 |
| PE20040562A1 (es) | 2004-10-19 |
| RU2005100509A (ru) | 2006-06-10 |
| AU2003236734A1 (en) | 2003-12-31 |
| CN100387298C (zh) | 2008-05-14 |
| EP1565211A2 (en) | 2005-08-24 |
| CU23552A1 (es) | 2010-07-20 |
| NO20050132L (no) | 2005-02-11 |
| JP2005531614A (ja) | 2005-10-20 |
| US20060110412A1 (en) | 2006-05-25 |
| AR040204A1 (es) | 2005-03-16 |
| ZA200409547B (en) | 2006-07-26 |
| NO20050132D0 (no) | 2005-01-11 |
| CL2003001192A1 (es) | 2005-01-07 |
| GB0213622D0 (en) | 2002-07-24 |
| CN1668329A (zh) | 2005-09-14 |
| NZ560766A (en) | 2009-09-25 |
| WO2003105890A3 (en) | 2004-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY27843A1 (es) | Composicion de vacuna | |
| BR0212999A (pt) | novas composições imunogênicas para a prevenção e tratamento de doença meningocócica | |
| EA200901161A1 (ru) | Вакцина против гриппа в виде эмульсии типа "масло в воде" | |
| BRPI0409459A (pt) | novas composições imunogênicas para a prevenção e tratamento de doença meningocócica | |
| PT1187629E (pt) | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador | |
| BRPI0519195A2 (pt) | composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal | |
| BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
| NO20082472L (no) | Vaksinesammensetninger omfattende en saponin adjuvant | |
| BRPI0510430A (pt) | composições e métodos para vacinação mucosal | |
| CY1111471T1 (el) | Μεθοδοι για τον καθαρισμο trans-(-)-δ9-τετραϋδροκανναβινολης και trans-(+)-δ9 τετραϋδροκανναβινολης | |
| BR0213358A (pt) | Uso de flibanserina | |
| BR0315767A (pt) | Composição imunogência, método para fabricar uma vacina, kit, vacina, recipiente com uma superfìcie interna repelente à água, e, método para preservar uma composição que compreende ipv e um agente estabilizador | |
| BRPI0516483A (pt) | preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade | |
| BRPI0407950A (pt) | processo para a preparação de uma composição de higiene pessoal | |
| NO20070746L (no) | Anvendelse av fosfaterte alkanoler som dispergente , emulgatorer, hydrotroper, fuktmidler og kompatabilitetsstoffer i blandinger for jordbruket. | |
| BRPI0407693A (pt) | uso de esteróides para preparação de formulações utilizáveis no tratamento de pessoas sofrendo de distúrbios oculares, bem como formulação assim obtidos | |
| EA200702254A1 (ru) | Вакцинная композиция, содержащая в-субъединицу термолабильного токсина e.coli и антиген и адъювант | |
| WO2007067519A3 (en) | The use of neurotransmitters and neuropeptides for the treatment of dry eye diseases and related conditions | |
| BRPI0407742A (pt) | uso de glicocorticóides para preparação de formulação utilizáveis no tratamento de angiogênese ocular patológica, bem como formulção assim obtida | |
| BR0208980A (pt) | Vacinas incluindo ifn do tipo i como um adjuvante e processos relacionados a esses | |
| RU2008144180A (ru) | Вакцина против микоплазмы и prrsv | |
| NZ591738A (en) | Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella | |
| BR0314821A (pt) | Derivado de piperidina, composição farmacêutica, uso do derivado de piperidina, e, método para tratamento, prevenção ou alìvio de uma doença ou um distúrbio ou uma condição de um corpo animal vivo | |
| BRPI0414527A (pt) | tratamento de tumores estromáticos gastrointestinais com imatinib e midostaurina | |
| WO2007027092A3 (en) | Oral composition for moisturising skin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2258 DE 15/04/2014. |